Oral cancer treatment: developments in chemotherapy and beyond
Top Cited Papers
Open Access
- 21 October 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 87 (9), 933-937
- https://doi.org/10.1038/sj.bjc.6600591
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial ResultsJournal of Clinical Oncology, 2002
- Phase II Study of Capecitabine and Oxaliplatin in First- and Second-Line Treatment of Advanced or Metastatic Colorectal CancerJournal of Clinical Oncology, 2002
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- Imatinib mesylate: Clinical results in philadelphia chromosome-positive leukemiasSeminars in Oncology, 2001
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal Of Cancer, 2001
- Preclinical pharmacology of BMS-275183, an orally active taxane.2001
- Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patientsCancer Chemotherapy and Pharmacology, 1999
- An economic evaluation of oral compared with intravenous ganciclovir for maintenance treatment of newly diagnosed for maintenance treatment of newly diagnosed cytomegalovirus retinitis in AIDS patientsClinical Therapeutics, 1996
- A study of quality of life in cancer patients receiving palliative chemotherapySocial Science & Medicine (1982), 1992
- Patient noncompliance with self-administered chemotherapyCancer, 1990